COPS6 and pancreatic neoplasm: We next established a subcutaneous xenograft model of pancreatic cancer in nude mice by injecting doxycycline (DOX)‐inducible CSN6‐KD cells to evaluate whether CSN6 depletion enhanced gemcitabine efficacy in vivo.